Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study.

Area of Science:

• Rheumatology
• Digital Health
• Health Services Research

Background:

• Rheumatic and musculoskeletal diseases (RMDs) require continuous monitoring, often challenged by appointment delays and patient adherence.
• Telemonitoring offers potential for enhanced RMD patient management and self-management.
• Improved patient-professional communication is crucial for managing chronic RMDs.

Purpose of the Study:

• To evaluate the clinical implementation of a hybrid care model, the mixed attention model (MAM).
• To determine if MAM improves clinical outcomes compared to conventional follow-up for RMD patients.

Main Methods:

• A multicenter prospective observational study involving 360 patients with rheumatoid arthritis (RA) and spondylarthritis (SpA).
• The MAM group uses a mobile app for remote monitoring and asynchronous professional review.
• A control group receives traditional face-to-face care; data includes clinical assessments and electronic patient-reported outcomes (ePROs).

Main Results:

• Participant recruitment is ongoing from March to December 2024.
• A 12-month follow-up period is planned for all patients.
• Data collection and analysis are expected to conclude by December 2025.

Conclusions:

• The study details the development and implementation of the MAM digital solution.
• The aim is to achieve significant economic and psychosocial impact by improving RMD control.
• This hybrid model seeks to enhance patient care and healthcare system efficiency.